Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05153109
Other study ID # 553
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date November 15, 2020
Est. completion date August 1, 2022

Study information

Verified date November 2021
Source Ruhr University of Bochum
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Kleinkind-DIPS (Diagnostisches Interview bei psychischen Störungen für Kleinkinder) is a structured interview to assess a variety of the most frequent psychological problems in babies and preschoolers, e.g. feeding or sleeping problems, anxiety disorders. It is administered by a trained clinician with one of the primary carers. In this study, its acceptance, reliability and validity will be tested in a clinical and non-clinical sample.


Description:

The Kleinkind- DIPS (Diagnostisches Interview bei psychischen Störungen für Kleinkinder) is a structured interview to assess a variety of the most frequent psychological of the most frequent psychological problems in babies and preschoolers, e.g. feeding or sleeping problems, anxiety disorders. It is administered by a trained clinician with one of the primary carers. In this study, its acceptance, reliability and validity will be tested in a clinical and non-clinical sample. Parts of the interview are adapted from the Kinder-DIPS, for which information on acceptance, reliability and validity are available. The aim of the present study is to test the interviews acceptance, reliability and validity in both a clinical and a non-clinical sample.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 150
Est. completion date August 1, 2022
Est. primary completion date August 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 71 Months
Eligibility Inclusion Criteria: sufficient knowledge of the German language - Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Ruhr-University Bochum North-Rhine Westphalia
Germany Ludwig Maximilian University of Munich Munich Bavaria

Sponsors (2)

Lead Sponsor Collaborator
Ruhr University of Bochum Ludwig-Maximilians - University of Munich

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Acceptance of the Interview Questionnaire assessing parents perception of the interview within one week after being interviewed
Primary Kleinkind-DIPS structured interview for parents of preschoolers within one week of the other measures
Secondary SFS-Fragebogen zum Schreien, Füttern, Schlafen Questionnaire assessing feeding, sleeping and crying in young infants within one week of the other measures; only for parents of children aged 18 months or younger
Secondary DASS-21 Depression Anxiety Stress Scale Questionnaire assessing depression, anxiety and stress of the parents within one week of the other measures;
Secondary PSCO- Parental sense of control Questionnaire assessing self-efficacy and sense of control of the parents within one week of the other measures;
Secondary SDQ-Strengths and Difficulties Questionnaire Questionnaire assessing internalizing and externalizing problems in children within one week of the other measures; only for parents of children aged 18 months or older
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04907903 - RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to COVID-19 N/A
Completed NCT04475055 - Reliability and Validity of the DIPS (Structured Interview) in a Community Sample
Completed NCT04450238 - The Dual Factor Model of Mental Health in Inpatients
Completed NCT04453475 - Feasibility and Benefits of Digital Services During the COVID19 Pandemic N/A
Recruiting NCT06011642 - Reliability and Validity of a Digital Version of a Structured Interview for Children and Adolescents (Kinder-eDIPS)
Completed NCT05238415 - ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19 N/A